An in vivo study of pha matrices of different chemical composition: tissue reaction and biodegradation

E I Shishatskaya , E D Nikolaeva , A V Goreva , C J Brigham , T G Volova , A J Sinskey

Genes & Cells ›› 2012, Vol. 7 ›› Issue (1) : 73 -80.

PDF
Genes & Cells ›› 2012, Vol. 7 ›› Issue (1) : 73 -80. DOI: 10.23868/gc121689
Articles
other

An in vivo study of pha matrices of different chemical composition: tissue reaction and biodegradation

Author information +
History +
PDF

Abstract

The study addresses consequences of subcutaneousimplantation of film matrices prepared from different PHAsto laboratory animals. No negative effects of subcutaneousimplantation of PHA matrices on physiological and biochemicalcharacteristics of the animals were determined. Independentlyof the matrices composition and duration of the contact withthe internal environment of the organism we did not observeany deviations in the behavior of animals, their growth anddevelopment, as well as blood functions. Response of thetissues to PHA matrices was comparable with the response topolylactide, but substantially less expressed at the earlier timeperiods after implantation. Tissues response to implantation ofPHA of all types is characterized by short-term (up to 2 weeks)post-traumatic inflammation with formation of fibrous capsulesby 30th-60th days with the thickness less than 100 microns,which get thinner down to 40-60 microns by 180th day as theresult of involution. No differences in response of tissues andthe whole organism were observed for the matrices producedfrom the homopolymer of 3-hydroxybutyric acid (P3HB),copolymers of 3-hydroxybutyric and 4-hydroxybutyric acids(P3HB/4HB), 3-hydroxybutyric acid and 3-hydroxyvalerianicacids (P3HB/3HV), 3-hydroxybutyric and 3-hydroxyhexanoateacids (P3HB/3HH). Macrophages and foreign-body giant cellsactively participate in the response of the tissues to PHAs. Inthe studied conditions matrices from the copolymers containing3-hydroxyhexanoate and 4 hydroxybutyrate were determined asmore actively degraded PHA. The next less degraded matriceswere matrices from the copolymer of P3HB/3HV and the mostresistant were P3HB matrices. The slower degradation of PHAmatrices was accompanied by delayed development of giantcellsresponse. The studied PHA matrices can be placed in thefollowing range by their degradation: P3HB/3HH - P3HB/4HB -P3HB/HV - P3HB.

Cite this article

Download citation ▾
E I Shishatskaya, E D Nikolaeva, A V Goreva, C J Brigham, T G Volova, A J Sinskey. An in vivo study of pha matrices of different chemical composition: tissue reaction and biodegradation. Genes & Cells, 2012, 7(1): 73-80 DOI:10.23868/gc121689

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Штильман М.И. Полимеры медико-биологическокого назна- чения. М: Академкнига; 2006.

[2]

Хенч Л., Джонс Д. Биоматериалы, искусственные органы и инжиниринг тканей. Серия «Мир биологии и медицины». М.: Тех- носфера; 2007.

[3]

Volova T.G. Polyhydroxyalkanoates - plastic materials of the 21st century: production, properties, application. NY: Nova Science Pub; 2004: 7.

[4]

Волова Т.Г., Севастьянов В.И., Шишацкая Е.И. Полиоксиал- каноаты - биоразрушаемые полимеры для медицины. Красноярск: «Платина»; 2006.

[5]

Sudesh K., Abe H., Doi Y. Synthesis, structure and properties of polyhydroxyalkanoates: biological polyesters. Prog. Polym. Sci. 2000; 25: 1503-55.

[6]

Hocking P., Marchessault R. Chemistry and technology of biodegradable polymers (G. Griffin (Ed.). Glasgow: Blackie; 1994.

[7]

Qu X.-H., Wu Q., Zhang K.-Y. Et al In vivo studies of poly(3- hydroxybutyrate-co-3-hydroxyhexanoate) based polymers: Biodegradation and tissue reactions. Biomaterials 2006; 27: 3540-8.

[8]

Zhou J., Peng S.-W., Wang Y.-Y. et al. The use of poly93- hydroxybutyrate-co-3-hydroxyhexanoate) scaffolds for tarsal repair in eyelid reconstruction in the rat. Biomaterials 2010; 31: 7512-8.

[9]

Ying T.H., Ishii D., Mahara A. et al. Scaffolds from electrospun polyhydroxyalkanoate copolimers: Fabrication, characterization, bioabsorbtion and tissue response. Biomaterials 2008; 29: 1307-17.

[10]

Williams D.F., Martin D.P., Horowitz D.M. et al. PHA applications: addressing the price performance issue. I. Tissue engineering. Int. J. Biol. Macromol. 1999; 25 :111-21.

[11]

Williams S.F., Martin D.P. Applications of PHAs in medicine and pharmacy. In: A. Steinbüchel, editor. Series of biopolymers in 10 vol. 2002; 4: 91-121.

[12]

Williams S.F., Martin D.P. Applications of PHAs in Medicine and Pharmacy. In: A. Steinbüchel, editor. Biopolymers. 2004; 4: 91-103.

[13]

Шишацкая Е.И., Волова Т.Г., Гордеев С.А. и др. Биодеграда- ция шовных нитей на основе полиоксиалканоатов в биологических средах. Перспективные материалы 2002; 2: 56-62.

[14]

Volova T.G., Shishatskaya E.I., Sevastianov V.I. et al. Results of biomedical investigations of PHB and PHB/PHV fibers. Biochemical Еngin. J. 2003; 16(2): 125-33.

[15]

Shyshatskaya E.I., Volova T.G., Efremov S.N. et al. Tissue response to the implantation of biodegradable polyhydroxyalkanoate sutures. J. Mat. Sci. 2004; 15 (6): 719-28.

[16]

Shyshatskaya E.I., Khlusov I.A., Volova T.G. A hybrid PHBhydroxyapatite composite for biomedical application: production, in vitro and in vivo investigation. J. Biomater. Sci. Polymer Edn. 2006; 17(5): 481-98.

[17]

Шишацкая Е.И. Биосовместимые и функциональные свой- ства гибридного композита полигидроксибутират/гидроксиапатит. Вестник трансплантологии и искусственных органов 2006; 3: 34-8.

[18]

Shishatskaya E.I., Goreva A.V., Voinova O.N. et al. Tissue reaction to intramascular injection of resorbable polymer microparticles. Bulletin of experimental biology and medicine 2007; 144(6): 786-90.

[19]

Shishatskaya E.I., Voinova O.N., Goreva A.V. et al. Biocompatibility of polyhydroxybutyrate microspheres: in vitro and in vivo evaluation. J. Mat. Sci. 2008; 19(6): 2493-502.

[20]

Шишацкая Е.И., Горева А.В., Калачева Г.С. и др. Распре- деление и резорбция полимерных микрочастиц в тканях внутрен- них органов лабораторных животных при внутривенном введении. Бюллетень экспериментальной биологии и медицины 2009; 11: 542-46.

[21]

Shishatskaya E.I., Goreva A.V., Kalacheva G.S. et al. Biocompatability and resorption of intravenously administered polymer microparticles in tissue of internalorgans of laboratory animals. J. Biomat. Sci. 2011; 22: 2185-203.

[22]

Шишацкая Е.И., Волова Т.Г., Гительзон И.И. Исследование токсикологических свойств полиоксиалканоатов в эксперименте in vivo. Доклады РАН 2002; 383 (4): 565-7.

[23]

Shyshatskaya E.I., Volova T.G. А comparative investigation of biodegradable polyhydroxyalkanoate films as matrices for in vitro cell cultures. J. Mat. Sci. 2004; 15(8): 915-23.

[24]

Николаева Е.Д., Шишацкая Е.И., Мочалов К.Е. и др. Срав- нительное исследование клеточных носителей, полученных из резорбируемых полигидроксиалканоатов различного химического состава. Клеточная трансплантология и тканевая инженерия 2011; 6(4): 54-63.

[25]

Лакин Г.Ф. Биометрия: учебное пособие для вузов. М.: Высшая школа; 1990.

[26]

Шехтер А.Б, Серов В.В. Воспаление и регенерация. М.: Ме- дицина; 1995.

[27]

Sevastianov V.I., Perovа N.V., Shishatskaya E.I. et al. Production of purified polyhydroxyalkanoates (PHAs) for applications in contact with blood. J. Biomat. Sci. 2003; 14: 1029-42

[28]

Shishatskaya E.I. Biomedical investigation, application of PHA. Macromol. Sympos. 2008; 269: 65-81.

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

135

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/